Epstein-Barr Virus (EBV) infection – the infection pathogen behind so-called 'glandular fever' – is a risk factor for multiple sclerosis (MS), but the exact mechanisms involved have been ...

A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments ...

In animal studies, a similar vaccine candidate from ModeX generated neutralising antibodies in mice, ferrets, and nonhuman primates that inhibited EBV entry into both B cells and epithelial cells ...

Plasmablastic lymphoma (PBL) is an aggressive B-cell lymphoma with plasmablastic features that occurs in immunodeficient patients and is usually associated with Epstein-Barr virus (EBV) infection. It ...

Immune cell populations of people with post-vaccination syndrome had lower levels of effector CD4 T cells and higher levels ...

A woman diagnosed with neuroblastoma in childhood has remained in remission for more than 18 years after being treated with ...

Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

A newly identified condition, called “post-vaccination syndrome” (PVS), appears to be linked to mRNA Covid vaccines.